AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32952230 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective alveolar decortication in the upper arch, with 3D collagen matrix
Number of subjects: 40
Study 32952230 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 36360714 — intervention group
Group type: EXPERIMENTAL
Intervention: Grit Wellbeing and Self-regulation Program (two sessions/week for six weeks)
Number of subjects: 194
Study 36360714 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 194
Study 35428629 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus two 30 min rehabilitation sessions 5 days/week
Number of subjects: 90
Study 35428629 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study 33660080 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute alcohol exposure via an aBAC clamp at 80 mg%
Number of subjects: 40
Study 33660080 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study 32090783 — intervention group
Group type: EXPERIMENTAL
Intervention: THPP plus enhanced usual care (EUC)
Number of subjects: 850
Study 32090783 — intervention group
Group type: COMPARATOR
Intervention: EUC-only
Number of subjects: 850
Study 36137691 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational Atherectomy (RA)
Number of subjects: 200
Study 36137691 — intervention group
Group type: COMPARATOR
Intervention: Modified Balloon (MB)
Number of subjects: 200
Study 36137691 — intervention group
Group type: COMPARATOR
Intervention: Super High-Pressure Balloon
Number of subjects: 200
Study 34185197 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin analogues (PROMID, CLARINET)
Number of subjects: 0
Study 34185197 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide receptor radionuclide therapy (PRRT) with 177-lutetium (NETTER-1 trial)
Number of subjects: 0
Study 34185197 — intervention group
Group type: EXPERIMENTAL
Intervention: mTOR inhibitor everolimus (RADIANT trials)
Number of subjects: 0
Study 34185197 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKI)
Number of subjects: 0
Study 33765749 — intervention group
Group type: EXPERIMENTAL
Intervention: C. albicans antigen
Number of subjects: 60
Study 33765749 — intervention group
Group type: COMPARATOR
Intervention: MMR vaccine
Number of subjects: 60
Study 35926931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine SR
Number of subjects: 360
Study 35926931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 33657007 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care CRP measurement
Number of subjects: 649
Study 34750317 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 48
Study 34750317 — intervention group
Group type: COMPARATOR
Intervention: 0.75% bupivacaine
Number of subjects: 48
Study 34070864 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary substitution of polyunsaturated fatty acids for saturated fatty acids; higher concentrations of dihomo‐?‐linolenic acid (20:3n6) and palmitoleic acid (16:1n7)
Number of subjects: 7526
Study 34070864 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetically predicted circulating dihomo‐?‐linolenic acid
Number of subjects: 7526
Study 32513153 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment from a physical therapist with more knowledge about work-related factors and skills in integrating work participation into care.
Number of subjects: 442
Study 32513153 — intervention group
Group type: COMPARATOR
Intervention: Normal physical therapy treatment.
Number of subjects: 442
Study 34927239 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Foundations program
Number of subjects: 0
Study 34927239 — intervention group
Group type: COMPARATOR
Intervention: Control families
Number of subjects: 0
Study 34820448 — intervention group
Group type: EXPERIMENTAL
Intervention: Different humidification devices and interfaces
Number of subjects: 0
Study 36375186 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) denervation of the medial branch of the spinal dorsal ramus
Number of subjects: 270
Study 36375186 — intervention group
Group type: COMPARATOR
Intervention: Conventional conservative approach
Number of subjects: 270
Study 32332710 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulations of glasses under compression with two length scales of particle interaction.
Number of subjects: 0
Study 36278359 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression Stockings (CS)
Number of subjects: 16
Study 36278359 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal Binders (AB)
Number of subjects: 16
Study 36278359 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 16
Study 34193047 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantothenic acid deficient (PAD) diet
Number of subjects: 128
Study 34193047 — intervention group
Group type: COMPARATOR
Intervention: Pantothenic acid adequate (control, CON) diet
Number of subjects: 128
Study 34193047 — intervention group
Group type: EXPERIMENTAL
Intervention: PAD diet
Number of subjects: 128
Study 36112182 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrocolpopexy (LSC)
Number of subjects: 74
Study 36112182 — intervention group
Group type: COMPARATOR
Intervention: Abdominal sacrocolpopexy (ASC)
Number of subjects: 74
Study 33599960 — intervention group
Group type: EXPERIMENTAL
Intervention: VP-102 (topical cantharidin 0.7% w/v)
Number of subjects: 528
Study 33599960 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 528
Study 33611699 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of Obstructive Sleep Apnea Syndrome (OSAS)
Number of subjects: 0
Study 33611699 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 35687774 — intervention group
Group type: EXPERIMENTAL
Intervention: Infraclavicular brachial plexus blockade with hydrodissection (15 mL distilled water + 15 mL 0.5% bupivacaine)
Number of subjects: 90
Study 35687774 — intervention group
Group type: COMPARATOR
Intervention: Infraclavicular brachial plexus blockade with normal method (30 mL local anesthetic mixture: 15 mL distilled water + 15 mL 0.5% bupivacaine)
Number of subjects: 90
Study 34126133 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel SGA
Number of subjects: 9296
Study 34126133 — intervention group
Group type: COMPARATOR
Intervention: Tracheal Intubation (TI)
Number of subjects: 9296
Study 33096356 — intervention group
Group type: EXPERIMENTAL
Intervention: Active hf-tRNS (100–640 Hz; 2 mA; 20 min)
Number of subjects: 36
Study 33096356 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 36
Study 33096356 — intervention group
Group type: EXPERIMENTAL
Intervention: Active hf-tRNS
Number of subjects: 36
Study 33331826 — intervention group
Group type: EXPERIMENTAL
Intervention: Web browser
Number of subjects: 38
Study 33331826 — intervention group
Group type: EXPERIMENTAL
Intervention: Federated search portal system
Number of subjects: 38
Study 33331826 — intervention group
Group type: COMPARATOR
Intervention: Unassisted
Number of subjects: 38
Study 36401445 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonated Ringer's solution (BRS)
Number of subjects: 63
Study 36401445 — intervention group
Group type: COMPARATOR
Intervention: Control group (sodium lactate Ringer's solution)
Number of subjects: 63
Study 32134288 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body skills group (MBSG) intervention
Number of subjects: 108
Study 32134288 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 108
Study 32031737 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-look endoscopy (SLE)
Number of subjects: 252
Study 32031737 — intervention group
Group type: COMPARATOR
Intervention: Non-second-look endoscopy (NSLE)
Number of subjects: 252
Study 35377393 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 312
Study 35377393 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 312
Study 34138791 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) with heartbeat-music interventions (recorded maternal lullaby and heartbeat for infants, recorded infant heartbeat and preferred music for mothers)
Number of subjects: 100
Study 34138791 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 32612816 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic zinc supplements for diarrhea treatment (20 mg/d for 10 days with each episode; TZ)
Number of subjects: 3407
Study 32612816 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily preventive zinc tablets (7 mg/d; PZ)
Number of subjects: 3407
Study 32612816 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient powder (10 mg/d zinc, 6 mg/d iron and 13 other micronutrients; MNP)
Number of subjects: 3407
Study 32612816 — intervention group
Group type: COMPARATOR
Intervention: Daily placebo powder
Number of subjects: 3407
Study 32612816 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study group (including TZ, PZ, MNP)
Number of subjects: 3407
Study 33955628 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam containing nicotinic acid hexyl ester, polyphenols, zinc, glycine, and caffeine
Number of subjects: 62
Study 33955628 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control foam
Number of subjects: 62
Study 33793261 — intervention group
Group type: EXPERIMENTAL
Intervention: Distinctive encoding (generate a distinctive feature of the designated target)
Number of subjects: 2
Study 33793261 — intervention group
Group type: COMPARATOR
Intervention: Shared encoding (generate a shared feature of all exemplars)
Number of subjects: 2
Study 32913174 — intervention group
Group type: EXPERIMENTAL
Intervention: Depilatory cream
Number of subjects: 80
Study 32913174 — intervention group
Group type: COMPARATOR
Intervention: Razor shaving
Number of subjects: 80
Study 36042635 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative medicine treatments (acupuncture including electroacupuncture, moxibustion, manual therapy-type massage)
Number of subjects: 30
Study 36042635 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical treatments (anti-inflammatory drugs and lifestyle change education)
Number of subjects: 30
Study 36042635 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 (physical role restriction area and mental health area)
Number of subjects: 30
Study 33078649 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) group counseling for 8 weeks
Number of subjects: 0
Study 33078649 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 36375479 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (1000 mg at weeks 0 and 2 intravenously)
Number of subjects: 101
Study 36375479 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (600 mg/m2 body surface area every 4 weeks intravenously for six doses)
Number of subjects: 101
Study 36375479 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 101
Study 36375479 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 101
Study 34098442 — intervention group
Group type: EXPERIMENTAL
Intervention: Chess-training program (12-week duration, two 60-minute sessions per week)
Number of subjects: 0
Study 36219057 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 645
Study 36219057 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 645
Study 33592815 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminiscence therapy-based care (RTBC)
Number of subjects: 150
Study 33592815 — intervention group
Group type: COMPARATOR
Intervention: Control care (CC)
Number of subjects: 150
Study 33345933 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical Resources for Effective Postpartum Parenting
Number of subjects: 60
Study 33345933 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 60
Study 35959834 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal needle (25G)
Number of subjects: 350
Study 35959834 — intervention group
Group type: COMPARATOR
Intervention: Conventional needle (25G)
Number of subjects: 350
Study 33839775 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive group (8 weekly in-person occupational therapy sessions with App-delivered home exercises)
Number of subjects: 32
Study 33839775 — intervention group
Group type: COMPARATOR
Intervention: App Alone group
Number of subjects: 32
Study 33839775 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive group
Number of subjects: 32
Study 33715136 — intervention group
Group type: EXPERIMENTAL
Intervention: FCU4Health (n=141)
Number of subjects: 240
Study 36159170 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine ministration with health education
Number of subjects: 200
Study 36159170 — intervention group
Group type: COMPARATOR
Intervention: Routine ministration care (Control)
Number of subjects: 200
Study 33630447 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic Ventral Hernia Repair (RVHR)
Number of subjects: 124
Study 33630447 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Ventral Hernia Repair (LVHR)
Number of subjects: 124
Study 32755531 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV group A (78.7%)
Number of subjects: 1417
Study 32755531 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV group B (21.3%)
Number of subjects: 1417
Study 32755531 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV-A genotype ON1 (98.0%)
Number of subjects: 1417
Study 32755531 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV-A genotype NA1 (2.0%)
Number of subjects: 1417
Study 32755531 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV-B genotype BA10
Number of subjects: 1417
Study 35834516 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure procedure
Number of subjects: 971
Study 33378563 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic light that changed spectrum and intensity across the scheduled 16-h waking day
Number of subjects: 14
Study 33378563 — intervention group
Group type: COMPARATOR
Intervention: Static light
Number of subjects: 14
Study 32731011 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (20-minute session)
Number of subjects: 92
Study 32731011 — intervention group
Group type: COMPARATOR
Intervention: Control group (20-minute case study session)
Number of subjects: 92
Study 32731011 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention
Number of subjects: 92
Study 32731011 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 36284013 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (0.2 mg) plus low-dose bupivacaine (0.25% Marcaine in 4 mL)
Number of subjects: 40
Study 36284013 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 40
Study 36284013 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine plus bupivacaine
Number of subjects: 40
Study 32078692 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation HydroCoil Embolic System (HES)
Number of subjects: 600
Study 32078692 — intervention group
Group type: COMPARATOR
Intervention: Bare platinum coil (BPC)
Number of subjects: 600
Study 32078692 — intervention group
Group type: COMPARATOR
Intervention: Both HES and BPC
Number of subjects: 600
Study 35604789 — intervention group
Group type: EXPERIMENTAL
Intervention: Insurance-mediated implicit bias
Number of subjects: 109
Study 35604789 — intervention group
Group type: EXPERIMENTAL
Intervention: Racial-Ethnic-mediated implicit bias
Number of subjects: 109
Study 33305474 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 50 U
Number of subjects: 100
Study 33305474 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 100 U
Number of subjects: 100
Study 33305474 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 200 U
Number of subjects: 100
Study 35922961 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraneural facilitation (INF)
Number of subjects: 28
Study 35922961 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 28
Study 32037254 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity statin therapy
Number of subjects: 102
Study 32037254 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity statin therapy
Number of subjects: 102
Study 32037254 — intervention group
Group type: EXPERIMENTAL
Intervention: High Lp(a) group (Lp(a) >20 mg/dl)
Number of subjects: 102
Study 35421070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Coaching (CBC)
Number of subjects: 98
Study 35421070 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control Group
Number of subjects: 98
Study 34334070 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 7
Study 33731180 — intervention group
Group type: EXPERIMENTAL
Intervention: Clamping of chest drain
Number of subjects: 122
Study 33731180 — intervention group
Group type: COMPARATOR
Intervention: Non-clamping of chest drain
Number of subjects: 122
Study 32248805 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics supplementation
Number of subjects: 99
Study 32248805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 35057557 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose ingestion
Number of subjects: 36
Study 35057557 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein ingestion
Number of subjects: 36
Study 35057557 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat ingestion
Number of subjects: 36
Study 35057557 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-meal ingestion
Number of subjects: 36
Study 32198616 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 0
Study 32198616 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 0
Study 33821937 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 week weight-management program
Number of subjects: 1267
Study 33821937 — intervention group
Group type: EXPERIMENTAL
Intervention: 52 week weight-management program
Number of subjects: 1267
Study 33821937 — intervention group
Group type: COMPARATOR
Intervention: Brief intervention (booklet on losing weight)
Number of subjects: 1267
Study 33283766 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg/day) + Amoxicillin (1 g/12 h) + Dexlansoprazole (60 mg/day) for 7 days
Number of subjects: 66
Study 33283766 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg/day) + Amoxicillin (1 g/12 h) + Dexlansoprazole (60 mg/day) for 10 days
Number of subjects: 66
Study 33283766 — intervention group
Group type: COMPARATOR
Intervention: Laboratory tests before and after treatment
Number of subjects: 66
Study 36334050 — intervention group
Group type: COMPARATOR
Intervention: WBRT (30 Gy) ± 10 Gy boost (arm A)
Number of subjects: 134
Study 36334050 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT ± boost with concomitant and maintenance TMZ for 2 years (arm B)
Number of subjects: 134
Study 34438976 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival instrumentation (SI) with local adjunctive use of hyaluronic acid (HA) gel
Number of subjects: 126
Study 34438976 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive use of local placebo
Number of subjects: 126
Study 32568196 — intervention group
Group type: EXPERIMENTAL
Intervention: Crenezumab 30 or 45 mg/kg intravenously every 4 weeks for 13 weeks
Number of subjects: 71
Study 32568196 — intervention group
Group type: EXPERIMENTAL
Intervention: Crenezumab 60 mg/kg intravenously every 4 weeks for 13 weeks
Number of subjects: 71
Study 32568196 — intervention group
Group type: EXPERIMENTAL
Intervention: Crenezumab 120 mg/kg intravenously every 4 weeks for 13 weeks
Number of subjects: 71
Study 32568196 — intervention group
Group type: EXPERIMENTAL
Intervention: Crenezumab during open-label extension (OLE) at originally assigned dose level, except for Cohort 3 (crenezumab 60 mg/kg during OLE)
Number of subjects: 71
Study 32568196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 34397104 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% PVP-I nasal irrigation
Number of subjects: 55
Study 34397104 — intervention group
Group type: COMPARATOR
Intervention: Normal saline irrigation (Control)
Number of subjects: 55
Study 34397104 — intervention group
Group type: COMPARATOR
Intervention: Comparison between PVP-I and Normal saline
Number of subjects: 55
Study 32196748 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption (∼10g/day increase)
Number of subjects: 0
Study 36050816 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics
Number of subjects: 234
Study 36050816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 34704716 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-needle technique (TN group [n = 25])
Number of subjects: 50
Study 34704716 — intervention group
Group type: COMPARATOR
Intervention: single-needle technique (SN group [n = 25])
Number of subjects: 50
Study 34871640 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth program targeting depression
Number of subjects: 125
Study 36127627 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression care intervention
Number of subjects: 391
Study 34647190 — intervention group
Group type: EXPERIMENTAL
Intervention: ELA + DCB
Number of subjects: 79
Study 34647190 — intervention group
Group type: COMPARATOR
Intervention: DCB
Number of subjects: 79
Study 33258781 — intervention group
Group type: EXPERIMENTAL
Intervention: Active telehealth (n=471)
Number of subjects: 1373
Study 33258781 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=293)
Number of subjects: 1373
Study 34767999 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM Sublingual Immunotherapy (SLIT) for 18 months
Number of subjects: 91
Study 34767999 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 18 months
Number of subjects: 91
Study 34767999 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM SLIT
Number of subjects: 91
Study 34767999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 34279606 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiology-guided incremental optimization strategy (PIOS)
Number of subjects: 260